Technology ❯ Artificial Intelligence ❯ Investment Opportunities ❯ Stock Performance

AI Stocks

Cramer Calls Pfizer ‘Uninvestible’ After Q3 Beat, Citing No Growth Engine and Seagen Letdown

Cramer casts Pfizer as a bond-like payout with no clear growth engine.

Caterpillar’s AI-Fueled Rally Meets a ‘Priced for Perfection’ Test Ahead of Earnings

Intuitive Surgical Soars 23% for the Week After Q3 Beat and Buyback

Intel’s 2025 Rally Tested by Bank of America Downgrade

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target